SCHEMBL8060408

SCHEMBL8060408

CN(C)C(=O)ON[C@@H](Cc1ccccc1)C(=O)OCCN1CCOCC1

nearest known ligand 0.53

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.53
TACR2 P21452 7/20 0.49
CNR2 P34972 2/20 0.47
MEN1 O00255 3/20 0.44
KMT2A Q03164 3/20 0.44
POLB P06746 1/20 0.44
CNR1 P21554 1/20 0.44
CYP1A2 P05177 1/20 0.43
CYP3A4 P08684 1/20 0.43
CYP2D6 P10635 1/20 0.43
CYP2C9 P11712 1/20 0.43
PKM P14618 1/20 0.43
CYP2C19 P33261 1/20 0.43
PRCP P42785 1/20 0.43
TMEM97 Q5BJF2 1/20 0.43
SIGMAR1 Q99720 1/20 0.43
BCHE P06276 1/20 0.43
ACHE P22303 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8060406 1.00 ALDH1A1 (0.53) ALDH1A1TACR2CNR2MEN1KMT2A
SCHEMBL8065025 0.78 MMP8 (0.50) ALDH1A1POLB
SCHEMBL8065032 0.78 MMP8 (0.50) ALDH1A1POLB
SCHEMBL7284529 0.77 ALDH1A1 (0.60) ALDH1A1TACR2CNR2MEN1KMT2A
SCHEMBL27463051 0.76 ALDH1A1 (0.66) ALDH1A1MEN1KMT2APOLBCYP1A2
SCHEMBL4443855 0.75 MMP9 (0.49) KMT2A
SCHEMBL4443858 0.75 MMP9 (0.49) KMT2A
SCHEMBL4550561 0.75 MMP9 (0.44) ALDH1A1POLBCYP2C9CYP2C19
SCHEMBL4550562 0.75 MMP9 (0.44) ALDH1A1POLBCYP2C9CYP2C19
SCHEMBL6428465 0.75 ALDH1A1 (0.55) ALDH1A1TACR2CNR2MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1000051-A1 CARBAMYLOXY COMPOUNDS WHICH INHIBIT LEUKOCYTE ADHESION MEDIATED BY VLA-4 Elan Pharmaceuticals, Inc. (US) 2000-05-17 EP disclosed
WO-1999006390-A1 CARBAMYLOXY COMPOUNDS WHICH INHIBIT LEUKOCYTE ADHESION MEDIATED BY VLA-4 ELAN PHARMACEUTICALS, INC. (US) 1999-02-11 WO disclosed